Discover our new oral solid dose (OSD) development capabilities at our Bend, Oregon site.
Viral vectors for cell and gene therapies hold transformative potential, offering unprecedented opportunities to treat and potentially cure a wide range of diseases. The path to the cure is complex, however, and each step requires careful attention.
This webinar explores the critical elements of viral vector production for cell and gene therapies, focusing on the technical and regulatory challenges inherent in this field. Our experts share detailed insights derived from our proprietary technologies and years of experience in advanced therapy medicinal products. We also discuss practical aspects of facility design and process optimization, emphasizing solutions that enhance both safety and efficacy in cell and gene therapy manufacturing.
Additionally, it guides participants through the regulatory landscape, highlighting strategies for navigating complex approval processes efficiently. Watch to learn how you can accelerate the path from laboratory to market for cell and gene therapies.
Key takeaways include: